Article
Predictors of Efficacy of Anamorelin in Non-small-cell Lung Cancer Patientswith Cachexia: A Retrospective Study
2023-06-13
Abstract excerpt
PURPOSE Anamorelin, a ghrelin receptor agonist, has recently been approved in Japan for the treatment of cachexia in patients with lung and gastrointestinal cancer. However, only a few studies have investigated whether anamorelin is actually useful in clinical settings. We therefore investigated its efficacy in terms of patient characteristics. METHODS We retrospectively evaluated 40 patients with non-small-cell...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1d37c5d9-35a1-5d65-83b4-5f3afcbb7f7e
- DOI
- 10.21203/rs.3.rs-3032275/v1
